Avicanna Expands its Derma-Cosmetics Brand Pura H&W™ into the European Union through a Partnership with Bio-Gate AG
April 05, 2022 07:30 ET
|
Avicanna Inc.
The exclusive distribution agreement includes 5 SKUs from Pura H&W’s evidence-based derma-cosmetics portfolio The products will be commercialized through Bio-Gate’s existing distribution channels...
Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2021
March 31, 2022 20:46 ET
|
Avicanna Inc.
$3.3M in revenue representing 108% Y-Y growth, significant growth in finished product sales Total of 4 brands, 16 SKU’s and 35 “cannabis 2.0” listings across medical and retail...
Avicanna Announces Closing of Non-Brokered Private Placement
March 31, 2022 17:00 ET
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Avicanna Enters into a Strategic Partnership with Tetra Bio-Pharma
February 14, 2022 07:30 ET
|
Avicanna Inc.
TORONTO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial-stage, and international biopharmaceutical...
Avicanna Provides Q4-2021 Results and Corporate Highlights as well as Fiscal 2022 Guidance
February 02, 2022 07:30 ET
|
Avicanna Inc.
TORONTO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial-stage, and international biopharmaceutical...
Avicanna Announces Closing of Non-Brokered Private Placement of Convertible Debenture Units
January 28, 2022 17:00 ET
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Avicanna Enters Master Supply Agreement with Chilean Pharmaceutical Pioneer Knop Laboratorios S.A.
January 14, 2022 07:30 ET
|
Avicanna Inc.
Expansion and fortification of relationship since 2020 with established pharmaceutical company in Chile Supply of Avicanna’s active pharmaceutical ingredients for existing commercial and pipeline...
Avicanna Announces the Appointment of Stephen Kim as Chief Legal Officer & General Counsel
January 10, 2022 07:30 ET
|
Avicanna Inc.
TORONTO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Avicanna USA Inc. together with Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on...
Avicanna Announces Changes to its Board of Directors
January 04, 2022 07:30 ET
|
Avicanna Inc.
TORONTO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing...
Avicanna Completes First Commercial Export of CBG Into the European Union
December 24, 2021 07:30 ET
|
Avicanna Inc.
First commercial export of Cannabigerol (CBG), a rare cannabinoid, into Czech Republic This export represents the 14th international market entrance for Avicanna products TORONTO, Dec. 24, 2021 ...